COVID-19 Law and Policy Briefings, Series Two: Vaccines, Equity, & Ethics
dc.ada.note | For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu | |
dc.contributor.group | George Consortium | |
dc.contributor.group | Center for Health Policy and Law (Northeastern University School of Law) | |
dc.contributor.group | Center for Public Health Law Research (Temple University Beasley School of Law) | |
dc.contributor.group | APHA Law Section | |
dc.creator | Mullen, Jewel | |
dc.creator | Zettler, Patricia | |
dc.creator | de Guia, Sarah | |
dc.date.accessioned | 2022-02-18T15:18:47Z | |
dc.date.available | 2022-02-18T15:18:47Z | |
dc.date.issued | 2020-11-19 | |
dc.description | The COVID-19 Law and Policy Briefings, hosted in two series from March 2020 through July 2021, feature US and international public health law experts discussing the biggest legal issues arising from the COVID-19 pandemic. The briefings are produced by the George Consortium, co-sponsored by the Center for Health Policy and Law at Northeastern University School of Law, the Center for Public Health Law Research at Temple University Beasley School of Law, and the APHA Law Section. Visit Public Health Law Watch (http://bit.ly/COVIDLawBriefing) to watch episodes. All past briefings are also archived by The Week in Health Law podcast. | |
dc.description.abstract | Recently, both Pfizer and Moderna have announced potential candidates for a COVID-19 vaccine. Patricia Zettler, Jewel Mullen, and Sarah de Guia discuss how the FDA issues emergency use authorizations (EUAs) for pharmaceutical products, related safety concerns, and how to equitably distribute a future COVID-19 vaccine. | |
dc.description.schoolcollege | Temple University. James E. Beasley School of Law | |
dc.format.extent | 00:22:30 | |
dc.identifier.citation | This Week in Health Law, COVID-19 Law and Policy Briefings, Series Two: Vaccines, Equity, & Ethics, (November 19, 2020), https://mcdn.podbean.com/mf/web/u7fy7i/twihl_220.mp3. | |
dc.identifier.uri | http://hdl.handle.net/20.500.12613/7386 | |
dc.language | English | |
dc.language.iso | eng | |
dc.relation.doi | http://dx.doi.org/10.34944/dspace/7364 | |
dc.relation.haspart | The Week in Health Law, Ep. 220 | |
dc.relation.ispartof | Center for Public Health Law Research | |
dc.relation.ispartof | COVID-19 Research | |
dc.relation.youtube | https://youtu.be/mbuq9GJg1Ds | |
dc.rights | All Rights Reserved | |
dc.subject | COVID-19 (Disease)--United States | |
dc.subject | COVID-19 Pandemic, 2020--United States | |
dc.subject | Public health laws | |
dc.subject | Vaccines--research | |
dc.subject | Drug development | |
dc.title | COVID-19 Law and Policy Briefings, Series Two: Vaccines, Equity, & Ethics | |
dc.type | Sound | |
dc.type.genre | Audio recording | |
refterms.dateFOA | 2022-02-18T15:18:47Z |
Files
Original bundle
1 - 1 of 1